SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Mazzarella who wrote (884)11/17/1996 1:41:00 PM
From: John H. Farro   of 4342
 
Richard, this meeting may be a marketing meeting and not a science meeting, but I don't see how the two can be separated. I think Dr. Babish would have to discuss the results of the Bastyr study at this meeting because those results will have a direct effect on the ability of the company to market the product. If they can't say that the results look promising after the study then I don't see how they will get people to buy the stuff. Of course, the sample size is so small that they won't be able to make any definitive claims; still it should be large enough to indicate that AndroVir has some promise.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News